Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and ...

Researchers characterized a new entity of non-scarring alopecia, macular alopecia, which is defined by small lesions and spontaneous resolution.

A higher intake of riboflavin was associated with a reduced risk of developing psoriasis, but no other single vitamin associations were observed.

Patients who develop LN within 1 to 5 years after SLE onset may face poorer renal outcomes compared with those who develop the disease earlier.

Few survivors of cancer with alcohol use disorder receive medication for the disorder, psychosocial therapy, or both.